Patients with chronic GvHD (cGvHD) produce excessive levels of B-cell activating factor (BAFF) which promotes B-cell survival and maturation and is associated with the production of pre-germinal center B-cells and post-germinal center plasma-like cells in patients with cGvHD [13]. The gene discussed is TNFSF13B; the disease is chronic graft versus host disease.